Black Hawk Acquisition Corp. to Acquire 03 Life Sciences
Ticker: BKHAR · Form: 8-K · Filed: Jun 27, 2025 · CIK: 2000775
| Field | Detail |
|---|---|
| Company | Black Hawk Acquisition CORP (BKHAR) |
| Form Type | 8-K |
| Filed Date | Jun 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, biotech
Related Tickers: BKHAU
TL;DR
BHAC buying 03 Life Sciences, moving into biotech.
AI Summary
Black Hawk Acquisition Corp. announced on June 27, 2025, that it has entered into a definitive agreement to acquire 03 Life Sciences, a company in the biological products sector. The filing does not disclose the financial terms of the acquisition at this time.
Why It Matters
This acquisition signals Black Hawk Acquisition Corp.'s strategic move into the biological products industry, potentially impacting its future growth and market position.
Risk Assessment
Risk Level: medium — Acquisitions, especially in the biotech sector, carry inherent risks related to integration, regulatory approvals, and market performance.
Key Players & Entities
- Black Hawk Acquisition Corp. (company) — Registrant
- 03 Life Sciences (company) — Target company
- June 27, 2025 (date) — Date of report and earliest event
FAQ
What is the nature of the business of 03 Life Sciences?
03 Life Sciences is in the business of Biological Products (No Diagnostic Substances), as indicated by its Standard Industrial Classification code [2836].
What is the filing date of this 8-K report?
The filing date of this 8-K report is June 27, 2025.
What is the principal executive office address for Black Hawk Acquisition Corp.?
The principal executive office address is 4125 Blackhawk Plaza Circle, Suite 166, Danville, CA 94506.
What is the fiscal year end for Black Hawk Acquisition Corp.?
The fiscal year end for Black Hawk Acquisition Corp. is November 30 (1130).
What is the SIC code for Black Hawk Acquisition Corp.'s industry?
The Standard Industrial Classification code for Black Hawk Acquisition Corp. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 27, 2025 regarding Black Hawk Acquisition Corp (BKHAR).